Working… Menu

A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04634409
Recruitment Status : Active, not recruiting
First Posted : November 18, 2020
Last Update Posted : September 5, 2021
AbCellera Biologics Inc.
Shanghai Junshi Bioscience Co., Ltd.
Vir Biotechnology, Inc.
Information provided by (Responsible Party):
Eli Lilly and Company